If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

Share Price is delayed by 15 minutes
Get Live Data
49.00    1.00 (2.08%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £44.80m
EMAN Live PriceLast checked at - London Stock Exchange

Intraday Everyman Media Share Chart

Trading Update

28 Jul 2025 07:00

RNS Number : 6856S
Everyman Media Group PLC
28 July 2025
 

Everyman Media Group PLC

("Everyman" or the "Group")

 

Trading Update

 

Everyman Media Group plc (AIM: EMAN) provides the following trading update for the 26 weeks ending 3 July 2025.

 

· Admissions of 2.2m (H1 2024: 1.9m), up 15%

· Group Revenue of £56.5m (H1 2024: £46.9m), up 21%

· Group EBITDA1 of £8.2m (H1 2024: £6.2m), up 33%

· Paid-for Average Ticket Price of £12.46 (H1 2024: £11.76), up 6.0%

· Food and Beverage Spend per Head of £11.09 (H1 2024: £10.47), up 5.9%

· Market Share of 5.8% (H1 2024: 5.6%), up 3.6%

· Net Debt of £24.2m (H1 2024: £25.8m), down 6.2%, with net debt repayment from operational cash flow expected in H2 2025.

 

Everyman now operates 48 cinemas, following the opening of a three-screen venue in Brentford in March 2025. A five-screen venue at The Whiteley in Bayswater is due to open in August 2025. No further openings are planned in 2025. The Group plans to open two additional venues in 2026, with a strong pipeline of future developments also in place.

 

In what is a challenging economic environment, the Group is currently trading in line with Board expectations for the full financial year.

 

The Group intends to publish its interim results for the 26 weeks ended 3 July 2025 on 24 September 2025.

 

Alex Scrimgeour, Chief Executive Officer of Everyman Media Group Plc, said:

 

"Our performance in H1 reflects the successful execution of our strategy, with growth across all key metrics and ongoing delivery of our measured expansion programme. This is driven by Everyman's unique brand of high-quality, experience-led cinema. We look forward to building on this momentum in the second half of the year."

 

1 Group EBITDA is measured on a post IFRS 16 basis.

 

For further information, please contact:

 

Everyman Media Group plc

Tel: 020 3145 0500

Alex Scrimgeour, Chief Executive

Will Worsdell, Finance Director

 

Canaccord Genuity Limited (NOMAD and Broker)

Tel: 020 7523 8000

Bobbie Hilliam

Harry Pardoe

Alma (Financial PR Advisor)

Tel: 020 3405 0205

Rebecca Sanders-Hewett

everyman@almastrategic.com

Joe Pederzolli

Emma Thompson

 

About Everyman Media Group PLC:

 

Everyman is the fourth largest cinema business in the UK by number of venues, and is a premium, high growth leisure brand. Everyman operates a growing estate of venues across the UK, with an emphasis on providing first class cinema and hospitality.

 

Everyman is redefining cinema. It focuses on venue and experience as key competitive strengths, with a unique proposition:

 

·

Intimate and atmospheric venues, which become a destination in their own right

·

An emphasis on a strong quality food and drink menu prepared in-house

·

A broad range of well-curated programming content, from mainstream and independent films to theatre and live concert streams, appealing to a diverse range of audiences

·

Motivated and welcoming teams

 

For more information visit http://investors.everymancinema.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKPBBABKDDOB
Date   Source Headline
31st Jan 20228:31 amRNSTotal Voting Rights
21st Jan 20227:00 amRNSTrading Update
20th Jan 20225:15 pmRNSExercise of Options
31st Dec 20217:00 amRNSBoard Change
22nd Nov 20217:00 amRNSTrading Update
28th Sep 202111:45 amRNSDirector/PDMR Shareholding replacement
28th Sep 20217:00 amRNSDirector/PDMR Shareholding
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20211:15 pmRNSExercise of Options & Total Voting Rights
30th Jul 20218:30 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSTrading Update
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSAppointment of Non-Executive Director
5th Jul 20215:30 pmRNSExercise of Options
1st Jul 202110:20 amRNSTotal Voting Rights
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
2nd Jun 202112:43 pmRNSResult of Annual General Meeting
1st Jun 20218:15 amRNSDirector/PDMR Shareholding
26th May 20214:35 pmRNSDirector/PDMR Shareholding
26th May 20214:29 pmRNSExercise of Options
10th May 20215:00 pmRNSPosting of Annual Report and Notice of AGM
7th May 20216:15 pmRNSDirector/PDMR Shareholding
8th Apr 20214:15 pmRNSDirector/PDMR Shareholding
8th Apr 20217:01 amRNSDirector/PDMR Shareholding
8th Apr 20217:00 amRNSFinal Results
23rd Mar 20217:00 amRNSDebt Facilities Update
22nd Mar 202110:30 amRNSHolding(s) in Company
1st Mar 202110:00 amRNSExercise of Options
14th Jan 20217:00 amRNSTrading Update
23rd Dec 20207:00 amRNSGrant of Options
18th Dec 20205:07 pmRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSBoard Appointment
2nd Dec 20208:00 amRNSHolding(s) in Company
2nd Dec 20208:00 amRNSHolding(s) in Company
16th Nov 20203:08 pmRNSGrant of Options
13th Nov 20209:50 amRNSHolding(s) in Company
9th Nov 20204:41 pmRNSSecond Price Monitoring Extn
9th Nov 20204:37 pmRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSCOVID-19 Update
3rd Nov 20202:05 pmRNSSecond Price Monitoring Extn
3rd Nov 20202:00 pmRNSPrice Monitoring Extension
3rd Nov 202011:05 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
20th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20204:15 pmRNSGrant of Options
30th Sep 20207:00 amRNSInterim Results
18th Sep 20207:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.